Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?
Open Access
- 15 April 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 29 (9) , 1710-1719
Abstract
The clinical effects of increased water intake on autosomal dominant polycystic kidney disease (ADPKD) progression are unknown. ADPKD patients with creatinine clearance ≧50 mL/min/1.73 m2 were divided into high (H-, n = 18) and free (F-, n = 16) water-intake groups, mainly according to their preference. Prior to the study, 30 patients underwent annual evaluation of total kidney volume (TKV) and 24-h urine for an average of 33 months. During the 1-year study period, TKV and 24-h urine were analyzed at the beginning and end of the study and every 4 months, respectively. During the pre-study period, urine volume (UV) in the H-group was higher (P = 0.034), but TKV and kidney function and their slopes were not significantly different between the two groups. After the study commenced, UV further increased (P < 0.001) in the H-group but not in the F-group. During the study period, TKV and kidney function slopes were not significantly different between the two groups (primary endpoint). Plasma copeptin was lower (P = 0.024) in the H-group than in the F-group. TKV and kidney function slopes became worse (P = 0.047 and 0.011, respectively) after high water intake (H-group) but not in the F-group. High UV was associated with increased urine sodium, and urine sodium positively correlated with the % TKV slope (P = 0.014). Although the main endpoint was not significant, high water intake enhanced disease progression in the H-group when compared with the pre-study period. These findings necessitate a long-term randomized study before drawing a final conclusion.Keywords
This publication has 44 references indexed in Scilit:
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney DiseaseNew England Journal of Medicine, 2012
- Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2012
- Tolvaptan in Autosomal Dominant Polycystic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2011
- Potentially Modifiable Factors Affecting the Progression of Autosomal Dominant Polycystic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2011
- Vascular consequences of dietary salt intakeAmerican Journal of Physiology-Renal Physiology, 2009
- Revised Equations for Estimated GFR From Serum Creatinine in JapanAmerican Journal of Kidney Diseases, 2009
- Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic TargetsPharmacological Reviews, 2009
- Unified Criteria for Ultrasonographic Diagnosis of ADPKDJournal of the American Society of Nephrology, 2009
- Vasopressin Directly Regulates Cyst Growth in Polycystic Kidney DiseaseJournal of the American Society of Nephrology, 2008
- Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney diseaseKidney International, 2003